Last mentioned: Mar 24, 2026
Q4 Earnings Release
Spectral AI reports Q4 revenue beat and introduces 2026 revenue guidance.
BARDA Award
Company receives $31.7 million in non-dilutive funding for the DeepView System.
Fiscal Year End
Spectral AI closes FY2025 with $19.7M in R&D revenue and $15.4M in cash.
Spectral AI reported a significant Q4 2025 earnings beat with revenue of $3.8 million and a surprise GAAP profit, bolstered by a recent $31.7 million BARDA award. The company has introduced its first revenue guidance for 2026, marking a critical transition from R&D to commercial-scale medical AI diagnostics.
Spectral AI (NASDAQ: MDAI) has been awarded $31.7 million in non-dilutive funding from BARDA to accelerate the development and clinical validation of its DeepView® System. This AI-powered diagnostic platform aims to provide rapid, accurate assessments of burn wounds and diabetic foot ulcers, potentially transforming emergency and routine wound care.